XTL Biopharmaceuticals
Investors Count
2Deal Terms
1Funding, Valuation & Revenue
2 Fundings
XTL Biopharmaceuticals's latest funding round was a IPO for $44M on September 27, 2000.
XTL Biopharmaceuticals's latest post-money valuation is from September 2000.
Sign up for a free demo to see XTL Biopharmaceuticals's valuations in September 2000 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
9/27/2000 | IPO | $44M | 1 | |||
Other Investors |
Date | 9/27/2000 | |
|---|---|---|
Round | IPO | Other Investors |
Amount | $44M | |
Investors | ||
Valuation | ||
Revenue | ||
Sources | 1 |
XTL Biopharmaceuticals Deal Terms
1 Deal Term
XTL Biopharmaceuticals's deal structure is available for 1 funding round, including their IPO from September 27, 2000.
Round | IPO |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO |
XTL Biopharmaceuticals Investors
2 Investors
XTL Biopharmaceuticals has 2 investors. The Challenge Fund-Etgar invested in XTL Biopharmaceuticals's Other Investors funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
1 Other Investors | Private Equity | Israel | ||||
Venture Capital | Israel |
First funding | ||
|---|---|---|
Last Funding | ||
Investor | ||
Rounds | 1 Other Investors | |
Board Seats | ||
Type | Private Equity | Venture Capital |
Location | Israel | Israel |
XTL Biopharmaceuticals Acquisitions
3 Acquisitions
XTL Biopharmaceuticals acquired 3 companies. Their latest acquisition was NeuroNOS on January 13, 2026.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/13/2026 | Seed / Angel | NeuroNOS | $2M | Corporate Majority | 3 | |
3/20/2024 | ||||||
9/21/2005 | Series B |
Date | 1/13/2026 | 3/20/2024 | 9/21/2005 |
|---|---|---|---|
Investment Stage | Seed / Angel | Series B | |
Companies | NeuroNOS | ||
Valuation | |||
Total Funding | $2M | ||
Note | Corporate Majority | ||
Sources | 3 |
Loading...